HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Udo Jeschke Selected Research

Peptides (Polypeptides)

10/2012Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
5/2010Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.
2/2009Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer.
5/2005Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Udo Jeschke Research Topics

Disease

111Neoplasms (Cancer)
12/2022 - 01/2005
78Breast Neoplasms (Breast Cancer)
04/2022 - 01/2005
37Ovarian Neoplasms (Ovarian Cancer)
02/2022 - 05/2005
36Carcinoma (Carcinomatosis)
03/2021 - 06/2004
22Neoplasm Metastasis (Metastasis)
01/2022 - 01/2005
21Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 02/2014
20Spontaneous Abortion (Miscarriage)
01/2022 - 05/2008
19Endometrial Neoplasms (Endometrial Cancer)
12/2022 - 07/2007
18Carcinogenesis
03/2021 - 01/2005
17Pre-Eclampsia (Preeclampsia)
01/2022 - 12/2005
17Habitual Abortion (Recurrent Miscarriage)
01/2022 - 12/2010
12Inflammation (Inflammations)
01/2022 - 03/2009
12Ovarian Epithelial Carcinoma
01/2022 - 10/2012
11Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022 - 08/2010
10Lymphatic Metastasis
01/2021 - 01/2005
10Adenocarcinoma
12/2019 - 01/2003
9Endometriosis
10/2021 - 01/2009
9Trophoblastic Neoplasms (Trophoblastic Tumor)
11/2016 - 06/2004
7Choriocarcinoma
03/2019 - 06/2011
6Noninfiltrating Intraductal Carcinoma (DCIS)
04/2022 - 01/2005
6Circulating Neoplastic Cells
01/2021 - 12/2012
6Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 07/2007
6Ductal Carcinoma
04/2014 - 01/2005
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2019 - 05/2005
5Carcinoma in Situ
07/2007 - 03/2005
4HELLP Syndrome
01/2022 - 02/2007
4Hydatidiform Mole (Molar Pregnancy)
01/2020 - 07/2007
4Endometrioid Carcinoma
01/2018 - 05/2005
4Infections
04/2013 - 01/2009

Drug/Important Bio-Agent (IBA)

42Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2005
33ParaffinIBA
01/2022 - 01/2003
28Hormones (Hormone)IBA
01/2021 - 06/2004
23Estrogen ReceptorsIBA
11/2021 - 07/2007
17Biomarkers (Surrogate Marker)IBA
10/2021 - 07/2012
17GlycodelinIBA
01/2021 - 03/2005
15Messenger RNA (mRNA)IBA
11/2021 - 03/2005
15Mucin-1 (CA 15-3 Antigen)IBA
02/2021 - 07/2007
14AntibodiesIBA
10/2021 - 05/2005
14AntigensIBA
01/2021 - 05/2005
14Galectin 1 (LGALS1)IBA
10/2019 - 06/2004
12CarbohydratesIBA
01/2021 - 05/2005
12Inhibins (Inhibin)IBA
09/2010 - 01/2005
11Galectins (Galectin)IBA
10/2022 - 05/2012
11CytokinesIBA
11/2021 - 09/2008
11Estrogens (Estrogen)FDA Link
01/2021 - 07/2007
11Estrogen Receptor alphaIBA
01/2018 - 12/2005
111-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
06/2017 - 06/2004
10Monoclonal AntibodiesIBA
05/2012 - 01/2005
10Activins (Activin)IBA
09/2010 - 01/2005
9Cadherins (E-Cadherin)IBA
01/2022 - 05/2005
9Steroid Receptors (Steroid Receptor)IBA
11/2019 - 05/2005
9Progesterone Receptors (Progesterone Receptor)IBA
11/2019 - 07/2007
8CA-19-9 Antigen (CA 19-9 Antigen)IBA
12/2022 - 05/2005
8GTP-Binding Proteins (G-Protein)IBA
11/2021 - 11/2012
8Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
01/2021 - 01/2013
8Galectin 3 (LGALS3)IBA
12/2020 - 02/2011
8Calcitriol Receptors (Calcitriol Receptor)IBA
10/2020 - 02/2012
8EpitopesIBA
02/2020 - 01/2007
8Thomsen-Friedenreich antigenIBA
02/2020 - 06/2005
8Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2020 - 05/2010
7Dinoprostone (PGE2)FDA Link
08/2021 - 01/2018
7Thyroid HormonesIBA
08/2021 - 10/2012
7Protein Isoforms (Isoforms)IBA
01/2021 - 10/2012
7Vitamin DFDA LinkGeneric
10/2020 - 10/2012
7Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
03/2019 - 07/2007
7Tumor Biomarkers (Tumor Markers)IBA
04/2014 - 01/2005
6Sialyl Lewis X AntigenIBA
12/2022 - 05/2005
6PPAR gammaIBA
01/2022 - 09/2007
6histone H3 trimethyl Lys4IBA
01/2022 - 03/2020
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2022 - 12/2008
6EnzymesIBA
11/2021 - 11/2006
6CateninsIBA
06/2021 - 07/2013
6SteroidsIBA
01/2021 - 07/2007
6LigandsIBA
01/2021 - 09/2007
6ProgesteroneFDA LinkGeneric
03/2019 - 07/2007
6Estrogen Receptor betaIBA
01/2009 - 12/2005
5Histones (Histone)IBA
11/2021 - 02/2017
5RNA (Ribonucleic Acid)IBA
07/2021 - 01/2013
5Biological ProductsIBA
07/2021 - 06/2005
5ProstaglandinsIBA
12/2020 - 07/2017
5DNA (Deoxyribonucleic Acid)IBA
11/2020 - 02/2014
5Formaldehyde (Formol)FDA Link
07/2020 - 07/2007
5human ERBB2 proteinIBA
01/2020 - 12/2015
5Neoplasm Antigens (Tumor Antigens)IBA
11/2016 - 05/2005
5Glycoproteins (Glycoprotein)IBA
07/2013 - 01/2007
4Lewis Blood Group AntigensIBA
01/2022 - 05/2005
4Lysine (L-Lysine)FDA Link
11/2021 - 03/2020
4Prostaglandin Receptors (Prostaglandin Receptor)IBA
03/2021 - 07/2017
4Indicators and Reagents (Reagents)IBA
01/2021 - 01/2009
4FSH Receptors (FSH Receptor)IBA
10/2019 - 01/2013
4progesterone receptor AIBA
01/2019 - 07/2007
4Oncogene Proteins (Oncogene Protein)IBA
10/2018 - 06/2016
4Estradiol (Delestrogen)FDA LinkGeneric
01/2013 - 07/2007
4Peptides (Polypeptides)IBA
10/2012 - 05/2005
3Retinoid X Receptors (Retinoid X Receptor)IBA
01/2022 - 01/2017
3TeaIBA
01/2022 - 01/2019
3PlatinumIBA
01/2022 - 10/2020
3Small Interfering RNA (siRNA)IBA
11/2021 - 01/2020
3Co-Repressor ProteinsIBA
11/2021 - 01/2019

Therapy/Procedure

39Therapeutics
02/2022 - 06/2005